LENZ Therapeutics, Inc. (LENZ)
NGM · Common · CUSIP 52635N103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for LENZ and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
52635N103 (prev. 38870X104 )
Market Cap
Large Cap
IPO
6/25/2021 · $17.00/share
Previous Symbol
GRPH (changed 3/22/2024)
Previous Name
Graphite Bio, Inc.
Business: Graphite Bio is a s a late-stage clinical company developing innovative ophthalmic pharmaceutical products. The Company's lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia.

Company Contact

CEO
Evert Schimmelpennink
CFO
Dan Chevallard
Headquarters
201 Haskins Way, Suite 210, South San Francisco, CA 94080
Phone
650-925-7000
Investor Relations
Julie Seidel · 212-698-8684 · Julie.seidel@sternir.com
SEC EDGAR Filings
View filings »